Natural killer cells: the secret weapon in dendritic cell vaccination strategies
/in Dendritic Cells, International PublicationsNovel approaches and mechanisms of immunotherapy for glioblastoma
/in Dendritic Cells, Glioblastoma, International PublicationsPhase I dendritic cell p53 peptide vaccine for head and neck cancer
/in Dendritic Cells, International PublicationsDasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaVaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
/in Dendritic Cells, Glioblastoma, International PublicationsLong-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant MelanomaPostoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International PublicationsConcomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
/in Dendritic Cells, International PublicationsDendritic cell-based vaccines: clinical applications in breast cancer
/in Breast Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer